Canada markets open in 3 hours 4 minutes

Barinthus Biotherapeutics plc (BRNS)

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Add to watchlist
2.2597+0.0497 (+2.25%)
At close: 04:00PM EDT
2.2100 -0.05 (-2.20%)
After hours: 07:34PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 88.35M
Enterprise Value -28.82M
Trailing P/E 6.97
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)255.25
Price/Book (mrq)0.50
Enterprise Value/Revenue -2.12
Enterprise Value/EBITDA -18.29

Trading Information

Stock Price History

Beta (5Y Monthly) -0.44
52-Week Change 3-7.94%
S&P500 52-Week Change 326.94%
52 Week High 35.1000
52 Week Low 31.6400
50-Day Moving Average 32.5237
200-Day Moving Average 32.8079

Share Statistics

Avg Vol (3 month) 322.02k
Avg Vol (10 day) 36.84k
Shares Outstanding 539.03M
Implied Shares Outstanding 639.1M
Float 827.28M
% Held by Insiders 13.68%
% Held by Institutions 147.66%
Shares Short (May 15, 2024) 49.05k
Short Ratio (May 15, 2024) 40.55
Short % of Float (May 15, 2024) 40.04%
Short % of Shares Outstanding (May 15, 2024) 40.02%
Shares Short (prior month Apr 15, 2024) 414.11k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-22,931.44%

Management Effectiveness

Return on Assets (ttm)-20.75%
Return on Equity (ttm)-34.88%

Income Statement

Revenue (ttm)334k
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -74.15M
Net Income Avi to Common (ttm)-70.66M
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)129.97M
Total Cash Per Share (mrq)3.33
Total Debt (mrq)12.81M
Total Debt/Equity (mrq)7.45%
Current Ratio (mrq)11.15
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)-59.57M
Levered Free Cash Flow (ttm)-45.26M